Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for melanoma.
Of Interest
Melanoma risk doubles among childhood cancer survivors
Childhood cancer survivors are more than twice as likely to develop melanoma as the general population, according to findings published in Journal of Clinical Oncology.
Immunotherapy Combinations Reign Supreme in Upfront Melanoma Management
Teresa Petrella, MD, MHSc, FRCPC, discusses long-term data that inform the sequencing of immunotherapy and targeted therapies for frontline melanoma.
Cost-of-Care Discussions Between Cancer Patients & Providers
Most physicians agree that patients should know how much they’re going to pay for treatment before deciding on a plan. According to a survey of breast cancer surgeons, 87 percent agreed with this. Yet, it’s only a minority of physicians who claim they have cost-of-care discussions with their patients.